European Union Reference Laboratories (EURLs) for in vitro diagnostic medical devices (IVDs) under the in vitro diagnostic medical devices Regulation (IVDR 2017/746)

The HPRA, as the national competent authority for in vitro diagnostic medical devices (IVDs) in Ireland, continues to seek expressions of interest (via email to from laboratories meeting the specified criteria (outlined below) to be designated as European Union (EU) reference laboratories (EURLs) by the European Commission. The HPRA requests that interested laboratories outline their particular areas of competence in relation to IVDs, when contacting the HPRA.

As recently announced on the HPRA website, the European Commission has launched a public consultation on two Implementing Acts (IAs) relating to EURLs:

  1. Tasks & Criteria: This act covers the criteria the EURLs must satisfy such as the qualifications of staff, confidentiality, accreditation, international standards and best practices and provides detailed rules to ensure compliance. In addition, the IA sets out further details regarding the tasks that EURLs carry out as well as rules to facilitate the application of those provisions. These rules relate to areas such as written contracts, the verification of performance and compliance with common specifications, requests from notified bodies or Member States, and sample/batch testing.
  2. EURL fees: This act sets out the structure of fees, the level of fees that can be applied and the rules surrounding the calculation of fees.

The public consultation is open until 17 December 2021. Feedback can be provided to the Commission via the above links.

The HPRA will continue to accept expressions of interest following the adoption of the Implementing Acts. It is anticipated that an official call for applications to become an EURL will be published by the European Commission during Q1 2022. The HPRA will provide an update when this call is published.


As detailed in the Regulation 2017/746 on in vitro diagnostic medical devices (IVDR), EURLs have a key role to play in verifying the safety and performance of IVDs both in the pre-market and post-market lifecycle of a device. Laboratories meeting the criteria for designation as a EURL (see below) are encouraged to apply for designation in order to contribute to a robust regulatory framework that will strengthen the European system of regulation and afford greater protection of public health. Where notified bodies or Member States request scientific or technical assistance or a scientific opinion from an EURL, they may be required to pay fees to wholly or partially cover the costs incurred by that laboratory in carrying out the requested task according to predetermined and transparent terms and conditions. The Implementing act on fees outlines the structure and the level of these fees taking into account the objectives of human health and safety protection, support of innovation and cost-effectiveness.

Criteria for Designation

Laboratories must satisfy specific criteria in order to be designated as an EURL. These criteria are specified in Article 100(4) of the IVDR such that a reference laboratory shall:

  • have adequate and appropriately qualified staff with adequate knowledge and experience in the field of the in vitro diagnostic medical devices for which they are designated;
  • possess the necessary equipment and reference material to carry out the tasks assigned to them;
  • have the necessary knowledge of international standards and best practices;
  • have an appropriate administrative organisation and structure;
  • ensure that their staff observe the confidentiality of information and data obtained in carrying out their tasks;
  • act in the public interest and in an independent manner;
  • ensure that their staff do not have financial or other interests in the in vitro diagnostic medical device industry which could affect their impartiality, declare any other direct and indirect interests they may have in the in vitro diagnostic medical device industry and update this declaration whenever a relevant change occurs.

Tasks of EU Reference Laboratories

The tasks of the IVD EURLs are outlined in Article 100 paragraph 2 (Class D) and Article 100 paragraph 3 (Class C) of the IVDR, and are as follows:

Class D

  • to verify the performance claimed by the manufacturer and the compliance of class D devices with the applicable CS, when available, or with other solutions chosen by the manufacturer to ensure a level of safety and performance that is at least equivalent, as provided for in the third subparagraph of Article 48(3);
  • to carry out appropriate tests on samples of manufactured class D devices or batches of class D devices, as provided for in Section 4.12 of Annex IX and in Section 5.1 of Annex XI;
  • to provide scientific and technical assistance to the Commission, the MDCG, the Member States and notified bodies in relation to the implementation of this Regulation;
  • to provide scientific advice regarding the state of the art in relation to specific devices, or a category or group of devices;
  • to set up and manage a network of national reference laboratories after consulting with the national authorities and publish a list of the participating national reference laboratories and their respective tasks;
  • to contribute to the development of appropriate testing and analysis methods to be applied for conformity assessment procedures and market surveillance;
  • to collaborate with notified bodies in the development of best practices for the performance of conformity assessment procedures;
  • to provide recommendations on suitable reference materials and reference measurement procedures of higher metrological order;
  • to contribute to the development of CS and of international standards;
  • to provide scientific opinions in response to consultations by notified bodies in accordance with this Regulation and publish them by electronic means having considered national provisions on confidentiality.

Class C

  • At the request of a Member State, the Commission may also designate the EU reference laboratories where that Member State wishes to have recourse to such laboratories to ensure the verification of the performance claimed by the manufacturer and the compliance of class C devices with the applicable CS when available, or with other solutions chosen by the manufacturer to ensure a level of safety and performance that is at least equivalent.


EURLs may be granted a Union financial contribution. The Commission may adopt, by means of implementing acts, the detailed arrangements and the amount of a Union financial contribution to the EURLs, taking into account the objectives of health and safety protection, support of innovation and cost-effectiveness. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 107(3).

Oversight of EU Reference Laboratories

EURLs shall be subject to controls, including on-site visits and audits, by the Commission to verify compliance with the requirements of this Regulation. If those controls find that an EURL is not complying with the requirements for which it has been designated, the Commission, by means of implementing acts, shall take appropriate measures, including the restriction, suspension or withdrawal of the designation.